Patient-reported outcome measures for a large cohort of serum eye drops recipients in the UK.

ABSTRACT:

Introduction

Serum eye drops (SED) are an important treatment for patients with chronic and severe ocular surface disease (OSD). Despite a long history of use, there is a paucity of information on patient-reported outcomes, particularly comparing autologous SED (Auto-SED) and allogeneic SED (Allo-SED). National Health Service Blood and Transplant is the national provider of SED service for patients in the UK.

Purpose

To evaluate and compare patient-reported outcome measures (PROMs) in patients receiving Auto-SED and Allo-SED for severe OSD.

Materials and methods

PROMs were retrospectively collected from all new patients commencing treatment with Auto-SED and Allo-SED between January 2017 and September 2018, using the Ocular Surface Disease Index (OSDI) 12-item questio

SUBMITTER: Lomas RJ 

PROVIDER: S-EPMC8602237 | biostudies-literature | 2021 Dec

REPOSITORIES: biostudies-literature